Effects of thoracic paravertebral nerve block combined with consciousness injury index monitoring on postoperative outcomes of Thoracoscopic lobectomy in the elderly

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030186

Enrollment

Unknown

Registered

2020-02-24

Start date

2020-02-28

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracoscopic lobectomy

Interventions

Group A:adjusted the target concentration of remifentanil according to the change of analgesic / anti injury index

Group B:adjusted the target concentration of remifentanil according to the change of hemodynamics

Eligibility

Sex/Gender

All

Age

65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Older than 65 years old; 2. Patients who will receive thoracoscopic lobectomy in our hospital; 3. ASA I - III; 4. Heart Function Level I - II; 5. Willing to participate in this trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. With congestive heart failure; 2. With severe abnormal liver and kidney function; 3. With spinal deformity, paraspinal space occupying; 4. Patients with complicated empyema and infection of puncture site; 5. Long-term history of taking diazepam, anti-sympathetic and antipsychotic medications.

Design outcomes

Primary

Measure	Time frame
Incidence of cardiopulmonary complications after surgery;	—

Countries

China

Contacts

Public ContactTianlong Wang

Xuanwu Hospital of Capital Medical University

w_tl5595@hotmail.com+86 13910525304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026